| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.091 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |